Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 26, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020706

« Back to Dashboard
NDA 020706 describes EMADINE, which is a drug marketed by Novartis Pharms Corp and is included in one NDA. It is available from one supplier. Additional details are available on the EMADINE profile page.

The generic ingredient in EMADINE is emedastine difumarate. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the emedastine difumarate profile page.

Summary for NDA: 020706

Therapeutic Class:Ophthalmic Agents

Pharmacology for NDA: 020706

Suppliers and Packaging for NDA: 020706

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
emedastine difumarate
SOLUTION/DROPS;OPHTHALMIC 020706 NDA Alcon Laboratories, Inc. 0065-0325 0065-0325-05 1 BOTTLE, PLASTIC in 1 CARTON (0065-0325-05) > 5 mL in 1 BOTTLE, PLASTIC

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION/DROPS;OPHTHALMICStrength0.05%
Approval Date:Dec 29, 1997TE:RLD:Yes

Expired Orange Book Patents for NDA: 020706

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis Pharms Corp
emedastine difumarate
SOLUTION/DROPS;OPHTHALMIC020706-001Dec 29, 19974,430,343► Subscribe
Novartis Pharms Corp
emedastine difumarate
SOLUTION/DROPS;OPHTHALMIC020706-001Dec 29, 19975,441,958► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus